Gehr, Sinje http://orcid.org/0000-0001-7589-9119
Kaiser, Thomas
Kreutz, Reinhold
Ludwig, Wolf-Dieter
Paul, Friedemann http://orcid.org/0000-0002-6378-0070
Article History
Received: 8 August 2019
Accepted: 18 October 2019
First Online: 22 November 2019
Compliance with ethical standards
:
: Sinje Gehr, Thomas Kaiser, and Wolf-Dieter Ludwig declare that they have no competing interest. Friedemann Paul received lectures fee/research support from Bayer/Novartis/Biogen Idec/TEVA/Sanovi–Aventis–Genzyme/Merck Serono, Alexion/Chugai/Medimmune/Roche/Chugai/Guthy Jackson Foundation. Furthermore, Friedemann Paul took part in the advisory boards of Novartis and Medimmune. Reinhold Kreutz declares that he consulted Bayer Pharma, Berlin–Chemie, Daiichi Sankyo, Ferrer, Sanofi, Servier. Additionally, he did research for Bayer Pharma.
: This article does not contain any studies with human participants or animals performed by any of the authors. The consent of the publication is not applicable. Ethical approval is not applicable.